Skip to main content
Equibles

FMR LLC

Position in EDIT — Editas Medicine, Inc.

CIK 315066 BOSTON, MA
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$360,281
+$96,535 QoQ
Shares Held
111,198
+4.1% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. EDIT ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in EDIT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $360,281 111,198
2026-03-31 $263,746 106,780
2025-12-31 $290,388 141,653
2025-09-30 $345,805 99,656
2025-06-30 $215,465 97,939
2025-03-31 $36,736 31,670
2024-12-31 $286,584 225,657
2024-09-30 $692,526 203,087
2024-06-30 $450,201 96,403
2024-03-31 $575,925 77,618
2023-12-31 $773,759 76,383
2023-09-30 $665,846 85,365
2023-06-30 $652,778 79,317
2023-03-31 $394,138 54,364
2022-12-31 $479,085 54,012
2022-09-30 $687,715 56,186
2022-06-30 $493,038 41,677
2022-03-31 $896,487 47,134
2021-12-31 $2,477,034 93,297
2021-09-30 $12,666,893 308,347
2021-06-30 $2,946,241 52,017
2021-03-31 $898,212 21,386
2020-12-31 $4,357,826 62,157
2020-09-30 $1,218,140 43,412
2020-06-30 $3,751,719 126,833
2020-03-31 $3,097,108 156,183